These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3140115)

  • 1. Effects of Hemophan and Cuprophan dialysis on beta-2 microglobulin levels, exercise capacity, and symptoms scores.
    Tomson CV; Woffindin C; Sheldon W; Hoenich NA
    Nephrol Dial Transplant; 1988; 3(3):355-6. PubMed ID: 3140115
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta2-microglobulin and IgE release during hemodialysis with cuprophan membrane.
    Stefanović V; Savić V; Rajić M; Mitić-Zlatković M
    Int J Artif Organs; 1997 Dec; 20(12):713-4. PubMed ID: 9506789
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes.
    Paczek L; Schaefer RM; Heidland A
    Nephron; 1990; 56(3):267-70. PubMed ID: 2077409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
    Sulková S; Votruba T; Lapcík O; Válek A
    Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta 2-microglobulin kinetics during hemodialysis with different membranes].
    Stetsiuk EA; Siniukhin VN; Danilkov AP; Shpazhnikova NS; Nikolaeva NP; Khamaganova EG
    Urol Nefrol (Mosk); 1995; (3):18-20. PubMed ID: 7618215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
    Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
    ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes.
    Schaefer RM; Paczek L; Heidland A
    Nephrol Dial Transplant; 1991; 6 Suppl 3():53-6. PubMed ID: 1775269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of beta 2-microglobulin by adsorption on dialysis membranes.
    Goldman M; Dhaene M; Vanherweghem JL
    Nephrol Dial Transplant; 1987; 2(6):576-7. PubMed ID: 3126461
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
    Schaefer RM; Hörl WH; Kokot K; Heidland A
    Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Binding and desorption of heparin to DEAE-cellulose dialysis membranes].
    Schmitt E; Holtz M; Esther G; Courtney JM; Klinkmann H
    Z Urol Nephrol; 1983; 76(2):99-108. PubMed ID: 6858414
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte elastase, beta-thromboglobulin, and C3d during acetate or bicarbonate hemodialysis with Hemophan compared to a cellulose acetate membrane.
    Stegmayr BG; Esbensen K; Gutierrez A; Lundberg L; Nielsen B; Stroemsaeter CE; Wehle B
    Int J Artif Organs; 1992 Jan; 15(1):10-8. PubMed ID: 1532382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
    Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of high-flux cellulose acetate and synthetic membranes.
    Hoenich NA; Woffindin C; Matthews JN; Goldfinch ME; Turnbull J
    Nephrol Dial Transplant; 1994; 9(1):60-6. PubMed ID: 8177478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of blood loss in dialysers with DEAE-cellulose membranes does not require increased doses of heparin.
    Ward RA; Schmidt B; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(10):1140-5. PubMed ID: 8272230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes.
    DeFranco P; Farrell J; Gellens M; Bastani B
    Am J Nephrol; 1998; 18(1):16-20. PubMed ID: 9481434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.